Stockscreener 앱 받기
13.38
7.28%
-1.05
시장 영업 전:
13.49
0.11
+0.82%
Erasca Inc 주식(ERAS)의 최신 뉴스
ERAS Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Securities Class Action Lawsuit Against Erasca, Inc. - Morningstar
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Erasca, Inc. Investors to Secure Counsel Before ... - Caledonian Record
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Erasca, Inc. - GlobeNewswire
Erasca, Inc. (ERAS) Faces Securities Class Action Amid - GlobeNewswire
ERAS Shareholder Alert: Erasca, Inc. Securities Class - GlobeNewswire
Erasca, Inc. (ERAS) Class Action Lawsuit: Levi & Korsinsky Reminds Investors of August 10, 2026 Deadline - ACCESS Newswire
INVESTOR NOTICE: Erasca, Inc. (ERAS) Investors with Substantial Losses Have Opportunity to Lead Investor Class Action LawsuitRGRD Law - marketscreener.com
INVESTOR NOTICE: Erasca, Inc. (ERAS) Investors with - GlobeNewswire
ERAS Stock Slumps Against RVMD Rally — Analyst Stays Bullish - Stocktwits
Frazier Life Sciences Management, L.P.'s Erasca Inc(ERAS) Holding History - GuruFocus
ERAS Stock Slumps Nearly 40% After-Hours: Fine Print In 'Positive' Cancer Trial Reveals Treatment-Related Death - Stocktwits
ERAS INVESTOR ALERT: Erasca, Inc. Investors with Substantial Losses Have Opportunity to Lead the Erasca Class Action Lawsuit - The Malaysian Reserve
Securities Fraud Investigation Into Erasca, Inc. (ERAS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm - The AI Journal
ROSEN, LEADING INVESTOR RIGHTS COUNSEL, Encourages Verra Mobility Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
FinancialContentErasca, Inc. (ERAS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation - FinancialContent
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Erasca, Inc. - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Erasca, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire
ERAS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire
Berger Montague PC Investigating Claims on Behalf of Erasca, Inc. (ERAS) Investors After Class Action Filing - marketscreener.com
Class action lawsuit filed against Erasca over misleading drug claims affecting investors. - Pluang
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Killeen Daily Herald
ERAS Investors Have Opportunity to Lead Erasca, Inc. Securities Fraud Lawsuit - Morningstar
INVESTOR ALERT: Securities Class Action Filed Against Erasca, Inc. – Investors Encouraged to Contact Kirby McInerney LLP - The Norfolk Daily News
Rosen Law Firm Urges Erasca, Inc. (NASDAQ: ERAS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights - The Joplin Globe
Bragar Eagel & Squire, P.C. Announces that a Class Action - GlobeNewswire
Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Erasca, Inc. and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
ERAS INVESTOR ALERT: Erasca, Inc. Investors with Substantial Los - GuruFocus
ERAS DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Erasca (ERA) Investors of Securities Class Action Lawsuit Deadline on August 10, 2026 - 巴士的報
Securities Fraud Investigation Into Erasca, Inc. (ERAS) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - Business Wire
ERAS INVESTOR ALERT: Class Action Lawsuit Filed on Behalf - GlobeNewswire
Erasca (ERAS) Receives Encouraging Expert Feedback on ERAS-0015 Clinical Trials - Insider Monkey
10 Best AI Driven Biotech Stocks to Invest In - Insider Monkey
Class action lawsuit filed against Erasca over alleged false statements and patent issues. - Pluang
Investor Notice: Robbins LLP Informs Investors of the Erasca, Inc. Class Action Lawsuit - The Joplin Globe
Erasca sued for securities fraud over misleading drug claims, stock drops 45%. - Pluang
SHAREHOLDER ALERT: Erasca, Inc. Sued For Securities Fraud by Block & Leviton LLP; August 10 ... - Caledonian Record
SHAREHOLDER ALERT: Erasca, Inc. Sued For Securities Fraud - GlobeNewswire
TNGX Stock Jumps 53% on Early Pancreatic Cancer Study Results - Yahoo Finance
Erasca Inc. (ERAS) Faces Selling Pressure as Shares Decline 3%KAMA Signal - newsline.com
BofA Securities Maintains Erasca(ERAS.US) With Hold Rating, Maintains Target Price $16 - Moomoo
Erasca (ERAS) Is Down 13.4% After IP Challenge to ERAS-0015 Trade Secrets and Patents - Yahoo Finance
Venrock Adviser, LLC's Erasca Inc(ERAS) Holding History - GuruFocus
Erasca Inc. (ERAS) Inspiring Confidence Through Commercial Collaborations - Insider Monkey
10 Most Promising Mid-Cap Healthcare Stocks According to Hedge Funds - Insider Monkey
Erasca earnings on deck after ERAS-0015 data sparks debate - Investing.com
Erasca earnings on deck after ERAS-0015 data sparks debate By Investing.com - Investing.com Nigeria
Erasca Shares Rise After BofA Upgrade - Moomoo
Erasca, Inc. (ERAS) Shares Crater 48%, Wiping Out $2.8 Billion of Market Cap; HBSS Investigating Intellectual Property Questions Regarding Lead Asset - Barchart.com
Erasca, Inc. Stock 12‑Month Price Target Raised to $20.91, Implies 59% Upside - TradingView
BofA Securities Upgrades Erasca(ERAS.US) to Hold Rating, Raises Target Price to $16 - Moomoo
BofA Securities Upgrades Erasca to Neutral From Underperform, Adjusts Price Target to $16 From $9 - marketscreener.com
This KeyBanc Analyst Turns Bullish; Here Are Top 4 Upgrades For Thursday - Benzinga
BofA upgrades Erasca stock rating on pan-RAS drug activity By Investing.com - Investing.com South Africa
BofA upgrades Erasca stock rating on pan-RAS drug activity - Investing.com
1.27%
1.43%
자본화:
|
볼륨(24시간):